Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE Trial
Circulation · 04.06.2024 · 149 (23) · 1802-1811
DOI: 10.1161/circulationaha.124.069494 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 04.06.2024. Verfasst von Alexander J Blood und 19 weiteren Autor:innen. Beteiligte Einrichtung: Accelerator for Clinical Transformation (A.J.B., S.H., J.C., G.S., D.G., D.Z., S.J.A., C.F., E.C., R.R., J.P., T.A.G., C.P.C., B.M.S.), Brigham and W…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Novo Nordisk, Inc.
Abstract (Originalsprache)
BACKGROUND: Several SGLT2i (sodium-glucose transport protein 2 inhibitors) and GLP1-RA (glucagon-like peptide-1 receptor agonists) reduce cardiovascular events and improve kidney outcomes in patients with type 2 diabetes; however, utilization remains low despite guideline recommendations. METHODS: A randomized, remote implementation trial in the Mass General Brigham network enrolled patients with type 2 diabetes with increased cardiovascular or kidney risk. Patients eligible for, but not prescribed, SGLT2i or GLP1-RA were randomly assigned to simultaneous virtual patient education with concurrent prescription of SGLT2i or GLP1-RA (ie, Simultaneous) or 2 months of virtual education followed by medication prescription (ie, Education-First) delivered by a multidisciplinary team driven by nonlicensed navigators and clinical pharmacists who prescribed SGLT2i or GLP1-RA using a standardized treatment algorithm. The primary outcome was the proportion of patients with prescriptions for either SGLT2i or GLP1-RA by 6 months. RESULTS: Between March 2021 and December 2022, 200 patients were randomized. The mean age was 66.5 years; 36.5% were female, and 22.0% were non-White. Overall, 30.0% had cardiovascular disease, 5.0% had cerebrovascular disease, and 1.5% had both. Mean estimated glomerular filtration rate was 77.9 mL/(min‧1.73 m 2 ), and mean urine/albumin creatinine ratio was 88.6 mg/g. After 2 months, 69 of 200 (34.5%) patients received a new prescription for either SGLT2i or GLP1-RA: 53.4% of patients in the Simultaneous arm and 8.3% of patients in the Education-First arm ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Accelerator for Clinical Transformation (A.J.B., S.H., J.C., G.S., D.G., D.Z., S.J.A., C.F., E.C., R.R., J.P., T.A.G., C.P.C., B.M.S.), Brigham and Women's Hospital, Boston, MA.
- Divisions of Cardiovascular Medicine (A.J.B., S.H., J.C., J.P., T.A.G., C.P.C., B.M.S.), Brigham and Women's Hospital, Boston, MA.
- Harvard Medical School, Boston, MA (A.J.B., L-S.C., C.C., J.P., T.A.G., C.P.C., D.J.W., B.M.S.).
- Endocrinology, Diabetes, and Hypertension (L-S.C.), Brigham and Women's Hospital, Boston, MA.
- Personalized Medicine, Mass General Brigham, Cambridge (S.J.A.).
- Novo Nordisk, Inc., Plainsboro, NJ (E.Z., J.N., C.R.).
ORCID-Profile: Alexander J Blood, Shahzad Hassan, Gretchen Stern, Daniel Gabovitch, David Zelle, Samuel J Aronson, Emily Zacherle, Carey Robar, Jorge Plutzky, Thomas A Gaziano, Christopher P Cannon, Deborah J Wexler
Förderung
- Novo Nordisk, Inc
Zitieren
APA
Blood, A. J., Chang, L. S., Hassan, S., Chasse, J., Stern, G., Gabovitch, D., Zelle, D., Colling, C., Aronson, S. J., Figueroa, C., Collins, E., Ruggiero, R., Zacherle, E., Noone, J., Robar, C., Plutzky, J., Gaziano, T. A., Cannon, C. P., Wexler, D. J., & Scirica, B. M. (2024). Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE Trial. Circulation, 149(23), 1802-1811. https://doi.org/10.1161/circulationaha.124.069494
Vancouver
Blood AJ, Chang LS, Hassan S, Chasse J, Stern G, Gabovitch D, et al. Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE Trial. Circulation. 2024;149(23):1802-1811. doi:10.1161/circulationaha.124.069494
BibTeX
@article{Blood2024,
author = {Blood, Alexander J and Chang, Lee-Shing and Hassan, Shahzad and Chasse, Jacqueline and Stern, Gretchen and Gabovitch, Daniel and Zelle, David and Colling, Caitlin and Aronson, Samuel J and Figueroa, Christian and Collins, Emma and Ruggiero, Ryan and Zacherle, Emily and Noone, Joshua and Robar, Carey and Plutzky, Jorge and Gaziano, Thomas A and Cannon, Christopher P and Wexler, Deborah J and Scirica, Benjamin M},
title = {Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE Trial},
journal = {Circulation},
year = {2024},
volume = {149},
number = {23},
pages = {1802--1811},
doi = {10.1161/circulationaha.124.069494}
}
EUVIMED